THE HYDRATEK® PROCESS


 
 

HRT®’s advanced HydraTek® process has produced an extensive product offering, including a variety of membrane products, a Cryo-preserved connective tissue matrix and the world’s first ambient temperature, connective tissue matrix allograft. This patent-pending formulation is the only one of its kind in market, and offers physicians and facilities an off-the-shelf, ready-to-use connective tissue matrix for homologous use.

HydraTek® allografts are not compromised by the industry’s standard drying methods, which may lead to protein denaturing and collagen collapse.

HydraTek® flowable grafts are uniquely processed to preserve the natural structure and biological integrity, providing the connective tissue matrix in its natural consistency for improved delivery and performance.

HydraTek® membrane allografts have optimally reduced hydration levels to provide ideal graft handling, strength and performance.


GROWTH FACTORS PRESERVED BY the HYDRATEK® PROCESS

 

SCAFFOLD COMPONENTS in placental tissues

Untitled-1-01.png

MMP INHIBITORS

MMPIcons-01-01.png
 

ANTI-INFLAMMATORIES